Two analytical approaches were used to extract differentially abundant transcripts from microarray. The classical approach is by normalization to median of all samples and by our alternative approach, normalization to individual baseline values. Genes from the classical approach were then validated by a technically independent method, the NanoString assay. At 2 weeks, 43 transcripts were consistently differentially abundant irrespective of platform and analytic method. MWU = Mann Whitney U test; BH-FDR = Benjamini-Hochberg corrected False Discovery Rate. Using the normalization to median approach, 125 genes were identified to be differentially abundant in TB-IRIS at week 2 (median time of symptom onset). Using the normalization to baseline approach, 281 genes were identified to be differentially abundant in TB-IRIS at week 2 (median time of symptom onset).
Upstream regulator prediction was performed using the transcriptomic signatures identified at week 2 (normalization to median method). An array of proinflammatory cytokines and transcription factors that regulate interferon and other cytokines were predicted to be activated (see also Figure 3 ). The activation z-score was calculated by matching observed and predicted up/down-regulation patterns based on the signatures. The p-value of overlap measures overlap of observed and predicted regulated gene sets using the Fisher's exact test.
Supplementary Table 6 . Validation of microarray data by NanoString assay
In a technically independent setup using probes with sequences different from the microarray, all but one of the 125 differentially abundant transcripts identified by the microarray at week 2 were validated by NanoString (see also Figure 3b ). The FLJ20273 gene was excluded due to poor probe specificity. Seventy-six transcripts were found to be significantly differentially abundant in 
